Simple Summary With the presented study, Fondazione Italiana Linfomi (FIL) researchers
want to fill a gap in the literature regarding long-lived lymphoma patients (beyond 5 years …

Lymphoma survivors after high-dose therapy with autologous stem-cell transplant (HDT-
ASCT) are at risk of several late effects, which might impair their health-related quality of life …

Introduction Adherence to healthy lifestyle recommendations has positive effects on cancer
outcomes yet adherence is low among cancer survivors. Differences in adherence between …

Purpose To investigate lifestyle in a population-based sample of long-term (≥ 5 years since
diagnosis) young adult cancer survivors (YACSs), and explore factors associated with not …

Although autologous hematopoietic cell transplantation (AHCT) is standard therapy for
patients with lymphoma and multiple myeloma (MM), few studies have addressed late …

Background Long-term lymphoma survivors often complain of persistent fatigue that remains
unexplained. While largely reported in Hodgkin lymphoma (HL), long-term fatigue is poorly …

In a world of digital solutions to almost every problem and a change in communication from
a hand-written letter traveling for weeks over long distances to short messages reaching you …

Dyslipidemia is one of the complications after allogeneic hematopoietic stem cell
transplantation (allo-HSCT), and it is often underestimated and undertreated. Dyslipidemia …

Reduced sexual function may have negative implications on health related quality of life
among lymphoma survivors. A national cross-sectional study among long-term lymphoma …

Purpose: Lymphoma survivors after high dose therapy with autologous stem cell therapy
(HD-ASCT) are at high risk for late adverse effects (AEs). Information patients receive and …